CN114369048A - Method for catalytically synthesizing astaxanthin - Google Patents
Method for catalytically synthesizing astaxanthin Download PDFInfo
- Publication number
- CN114369048A CN114369048A CN202111569916.5A CN202111569916A CN114369048A CN 114369048 A CN114369048 A CN 114369048A CN 202111569916 A CN202111569916 A CN 202111569916A CN 114369048 A CN114369048 A CN 114369048A
- Authority
- CN
- China
- Prior art keywords
- astaxanthin
- compound
- reaction
- ethanol
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000013793 astaxanthin Nutrition 0.000 title claims abstract description 63
- 239000001168 astaxanthin Substances 0.000 title claims abstract description 54
- 229940022405 astaxanthin Drugs 0.000 title claims abstract description 54
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 title claims abstract description 49
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 title claims abstract description 49
- 238000000034 method Methods 0.000 title claims abstract description 37
- 230000002194 synthesizing effect Effects 0.000 title claims abstract description 16
- 238000006243 chemical reaction Methods 0.000 claims abstract description 40
- 239000003513 alkali Substances 0.000 claims abstract description 28
- 239000002585 base Substances 0.000 claims abstract description 21
- 239000002904 solvent Substances 0.000 claims abstract description 20
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 claims abstract description 18
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 claims abstract description 17
- 239000011541 reaction mixture Substances 0.000 claims abstract description 12
- 238000001816 cooling Methods 0.000 claims abstract description 10
- 238000006386 neutralization reaction Methods 0.000 claims abstract description 8
- 238000003756 stirring Methods 0.000 claims abstract description 8
- 239000002253 acid Substances 0.000 claims abstract description 7
- 150000001875 compounds Chemical class 0.000 claims abstract description 6
- 239000012074 organic phase Substances 0.000 claims abstract description 5
- 238000002156 mixing Methods 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 86
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 63
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 41
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 238000010992 reflux Methods 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- 238000007036 catalytic synthesis reaction Methods 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 7
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 claims description 4
- 239000012456 homogeneous solution Substances 0.000 claims description 4
- 239000000725 suspension Substances 0.000 claims description 4
- 229910052783 alkali metal Inorganic materials 0.000 claims description 3
- 238000006317 isomerization reaction Methods 0.000 claims description 3
- 239000012454 non-polar solvent Substances 0.000 claims description 3
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims description 3
- 239000005456 alcohol based solvent Substances 0.000 claims description 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 claims description 2
- 150000001340 alkali metals Chemical group 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 239000012046 mixed solvent Substances 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims description 2
- 159000000000 sodium salts Chemical group 0.000 claims description 2
- MQZIGYBFDRPAKN-UWFIBFSHSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-UWFIBFSHSA-N 0.000 description 14
- 239000000463 material Substances 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- RASZIXQTZOARSV-BDPUVYQTSA-N astacin Chemical compound CC=1C(=O)C(=O)CC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)C(=O)CC1(C)C RASZIXQTZOARSV-BDPUVYQTSA-N 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 239000012065 filter cake Substances 0.000 description 10
- 239000012071 phase Substances 0.000 description 10
- 238000005406 washing Methods 0.000 description 10
- 230000008569 process Effects 0.000 description 8
- 102000034498 Astacin Human genes 0.000 description 6
- 108090000658 Astacin Proteins 0.000 description 6
- FMKGDHLSXFDSOU-BDPUVYQTSA-N Dienon-Astacin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(=CC1(C)C)O)C=CC=C(/C)C=CC2=C(C)C(=O)C(=CC2(C)C)O FMKGDHLSXFDSOU-BDPUVYQTSA-N 0.000 description 6
- 229960000583 acetic acid Drugs 0.000 description 6
- 235000003676 astacin Nutrition 0.000 description 6
- 239000012362 glacial acetic acid Substances 0.000 description 6
- 239000011259 mixed solution Substances 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 5
- 238000007239 Wittig reaction Methods 0.000 description 5
- 238000009835 boiling Methods 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- SMEOIWGPBCHFNQ-SNXZXGPZSA-N semiastacin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(=O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C SMEOIWGPBCHFNQ-SNXZXGPZSA-N 0.000 description 5
- 239000001632 sodium acetate Substances 0.000 description 5
- 235000017281 sodium acetate Nutrition 0.000 description 5
- ZNCPFRVNHGOPAG-UHFFFAOYSA-L sodium oxalate Chemical compound [Na+].[Na+].[O-]C(=O)C([O-])=O ZNCPFRVNHGOPAG-UHFFFAOYSA-L 0.000 description 5
- 229940039790 sodium oxalate Drugs 0.000 description 5
- 238000000967 suction filtration Methods 0.000 description 5
- 238000005292 vacuum distillation Methods 0.000 description 5
- 238000001291 vacuum drying Methods 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000004280 Sodium formate Substances 0.000 description 3
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 3
- 235000019254 sodium formate Nutrition 0.000 description 3
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical group CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000003444 phase transfer catalyst Substances 0.000 description 2
- 235000011056 potassium acetate Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- OCKGFTQIICXDQW-ZEQRLZLVSA-N 5-[(1r)-1-hydroxy-2-[4-[(2r)-2-hydroxy-2-(4-methyl-1-oxo-3h-2-benzofuran-5-yl)ethyl]piperazin-1-yl]ethyl]-4-methyl-3h-2-benzofuran-1-one Chemical compound C1=C2C(=O)OCC2=C(C)C([C@@H](O)CN2CCN(CC2)C[C@H](O)C2=CC=C3C(=O)OCC3=C2C)=C1 OCKGFTQIICXDQW-ZEQRLZLVSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 description 1
- UAEPNZWRGJTJPN-UHFFFAOYSA-N Methylcyclohexane Natural products CC1CCCCC1 UAEPNZWRGJTJPN-UHFFFAOYSA-N 0.000 description 1
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- -1 alkali metal alkoxide Chemical class 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 235000012682 canthaxanthin Nutrition 0.000 description 1
- 239000001659 canthaxanthin Substances 0.000 description 1
- 229940008033 canthaxanthin Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 238000012824 chemical production Methods 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 150000001934 cyclohexanes Chemical class 0.000 description 1
- IRXRGVFLQOSHOH-UHFFFAOYSA-L dipotassium;oxalate Chemical compound [K+].[K+].[O-]C(=O)C([O-])=O IRXRGVFLQOSHOH-UHFFFAOYSA-L 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- GYNNXHKOJHMOHS-UHFFFAOYSA-N methyl-cycloheptane Natural products CC1CCCCCC1 GYNNXHKOJHMOHS-UHFFFAOYSA-N 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 125000006574 non-aromatic ring group Chemical group 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000003003 phosphines Chemical class 0.000 description 1
- 150000004714 phosphonium salts Chemical class 0.000 description 1
- 239000004300 potassium benzoate Substances 0.000 description 1
- 235000010235 potassium benzoate Nutrition 0.000 description 1
- 229940103091 potassium benzoate Drugs 0.000 description 1
- WFIZEGIEIOHZCP-UHFFFAOYSA-M potassium formate Chemical compound [K+].[O-]C=O WFIZEGIEIOHZCP-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 229960004249 sodium acetate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- NESLWCLHZZISNB-UHFFFAOYSA-M sodium phenolate Chemical compound [Na+].[O-]C1=CC=CC=C1 NESLWCLHZZISNB-UHFFFAOYSA-M 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
- C07C403/24—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by six-membered non-aromatic rings, e.g. beta-carotene
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/09—Geometrical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
A method for catalytically synthesizing astaxanthin, comprising the steps of: 1) putting the compound II and the compound III in a solvent according to the molar ratio of 2.05-2.1: 1, adding weak base, stirring, mixing, cooling and controlling the temperature to be minus 25-minus 10 ℃; 2) controlling the temperature to be minus 25 ℃ to minus 10 ℃, and dropwise adding an alkali liquor into the reaction mixture in the step 1) in a continuous mode, wherein the molar ratio of the alkali in the alkali liquor to the compound II is 1.4-2.5: 1; 3) after the reaction is completed, adding acid for neutralization, extracting and separating, and concentrating the organic phase to obtain the compound I.
Description
Technical Field
The invention relates to a cyclohexane derivative with at least four carbon acyclic unsaturated side chains substituted by six-membered non-aromatic rings, in particular to a preparation method of astaxanthin.
Background
Astaxanthin, also known as Astaxanthin, is a fat-soluble carotenoid, the English name Astaxanthin, the chemical name 3, 3 ' -dihydroxy-4, 4 ' -diketo-beta, beta ' -carotene, of formula C40H52O4And 596.86, a reddish brown to brown powder with high heat resistance and poor light resistance. It has unique coloring function, antioxidant, anticancer, ultraviolet ray damage resisting and other functions, and may be used widely in food, feed, cosmetics, medicine and other fields. The chemical structure of the compound is a six-section ring structure formed by connecting four isoprene units in a conjugated double bond mode and two isoprene units at two ends, and the structure is shown as follows:
the process route for chemically synthesizing astaxanthin has the advantage of low cost, and the synthesis route comprises the following steps: 2C15+ C10 ═ C40; c20+2C10 ═ C40; canthaxanthin is used as a raw material, and three synthetic routes are provided. 2C15+ C10 ═ C40 is a main route for industrially producing astaxanthin, and the route adopts a WITTIG reaction between a C15 phosphonium salt and a C10 dialdehyde under the action of alkali, the alkali is mainly strong base, such as hydroxide or alkali metal alkoxide which is used in DE19509955A1, and strong base sodium methylate is used in CN101454280B, but the strong base is too strong in the synthesis process of the astaxanthin, so that byproducts such as astacin and hemishrimps can be generated, the yield of reactants is reduced, the reaction conditions are not easy to control, the control of the reaction conditions is strict, and the industrial production is difficult to control. There is a literature reporting a synthesis method (eur.j.org.chem.2000, 829-836) using butylene oxide as a weak base to finally form astaxanthin through WITTIG reaction, and the advantage of using butylene oxide as a weak base is that anions (e.g., bromide) of phosphine salt are captured to be chemically bonded, but butylene oxide is a relatively expensive carcinogen and is itself flammable and explosive, and is not suitable for use in green continuous chemical production. Therefore, the further improvement of the synthetic astaxanthin route of 2C15+ C10 ═ C40 and the improvement of the yield of the reaction become problems to be solved in the prior art.
Disclosure of Invention
Aiming at the problems, the invention provides a method for catalytically synthesizing astaxanthin, which has the advantages of simple, safe and green catalyst source, high yield, easily controlled process conditions, less side reaction and the like.
In order to solve the problems, the technical scheme provided by the invention is as follows:
a method for catalytically synthesizing astaxanthin,
the reaction formula is as follows
The method comprises the following steps:
a method for the catalytic synthesis of astaxanthin, comprising the steps of:
1) dissolving a compound II and a compound III in a solvent, adding weak base, stirring, mixing and cooling, and controlling the temperature to be minus 25 ℃ to minus 10 ℃;
2) adding strong alkali liquor into the reaction mixture in the step 1) at a temperature of between-25 ℃ and-10 ℃ for reaction;
3) after the reaction is completed, adding acid for neutralization, extracting and separating, and concentrating the organic phase to obtain the compound I.
The method for catalytically synthesizing the astaxanthin further comprises the following steps: in the step 1), the weak base is selected from sodium salt or potassium salt of weak organic acid, preferably, the weak base is selected from one or more of sodium benzoate, sodium phenolate, sodium formate, sodium oxalate, sodium acetate, potassium benzoate, potassium formate, potassium oxalate and potassium acetate.
The method for catalytically synthesizing the astaxanthin further comprises the following steps: in the step 2), the strong alkali liquor is a homogeneous solution or suspension selected from alkali metal alcoholate, alkali metal hydroxide and butyl lithium; the strong alkali solution is a homogeneous solution or suspension of sodium hydroxide or potassium hydroxide in ethanol, the ethanol for preparing the strong alkali solution contains 8-10% of water by weight, and the mass ratio of the ethanol to dichloromethane in a solvent is 0.7-0.8: 1.
the molar ratio of the alkali in the strong alkali solution to the compound II is 1.4-2.5: 1, and preferably 1.4-1.8: 1.
The method for catalytically synthesizing the astaxanthin further comprises the following steps: in the step 1), the molar ratio of the compound II to the compound III is 2.0-2.2: 1; the molar ratio of the weak base to the compound II is 0.5-1.5: 1, preferably 0.8-1.2: 1.
the method for catalytically synthesizing the astaxanthin further comprises the following steps: in step 1), the solvent is selected from an alcohol solvent, a mixture of different alcohol solvents or a mixed solvent consisting of alcohol and a water-immiscible nonpolar solvent, preferably, the alcohol solvent is selected from methanol, ethanol, 1-propanol, 2, propanol and n-butanol; the water-immiscible non-polar solvent is selected from dichloromethane, ethyl acetate, methyl acetate, cyclohexane or toluene.
The method for catalytically synthesizing the astaxanthin further comprises the following steps: in the step 1), the solvent is ethanol and dichloromethane in a mass ratio of 0.3-0.4: 1, and the water content of the ethanol in the solvent is 8-10% by weight; the mass ratio of the solvent to the compound II is 4: 13 to 14.
The method for catalytically synthesizing the astaxanthin further comprises the following steps: in the step 2), the strong alkali liquor is continuously dripped into the reaction mixture in the step 1), the reaction time of dripping the strong alkali liquor into the reaction mixture in the step 1) is 4-10h, preferably 4-6h, and after dripping is finished, the reaction is carried out for 1-6h, preferably 3-5h at-25 to-10 ℃.
The method for catalytically synthesizing the astaxanthin further comprises the following steps: in step 3), the acid is 5% dilute sulfuric acid or glacial acetic acid, and is neutralized until the pH value of the solution is 2-7, preferably 3-5.
The method for catalytically synthesizing astaxanthin further comprises the following step 4): adding ethanol into the compound I obtained by concentrating the organic phase in the step 3), heating and refluxing for 3-4 h, converting astaxanthin into full- (E) -isomer through thermal isomerization, and then cooling, filtering and drying to obtain an astaxanthin finished product.
The invention provides a method for catalytically synthesizing astaxanthin, which adopts weak base sodium formate, sodium acetate and sodium oxalate as phase transfer catalysts for wittig reaction, and H removed in the reaction process+Firstly, reacting with weak base to generate corresponding weak acid to promote the forward progress of wittig reaction; the weak acid then reacts with the potassium hydroxide/sodium hydroxide to form the corresponding weak base. Compared with the prior art, the method has the following beneficial effects: (1) the novel method uses weak base sodium formate, sodium acetate and sodium oxalate as phase transfer catalysts for wittig reaction, and the catalysts are simple in source, safe, environment-friendly and low in economic cost; (2) less by-products such as semiastacin and astacin are formed in the process of the invention, and by means of the above preferred process conditions, the semiastacin and astacin contents will be reduced to a minimum, the semiastacin content being reduced to < 0.9%, the astacin content being reduced to < 0.4%, (3) the process conditions in the process of the invention are easier to control, and the conditions are less demanding. The astaxanthin obtained by the process of the invention is mostly converted into the particularly desired all- (E) -isomer (all-trans astaxanthin) by thermal isomerization, usually by heating in ethanol.
Detailed Description
In order to make the objects, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention are clearly and completely described below, and it is obvious that the described embodiments are a part of the embodiments of the present invention, but not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The molar yield of all-trans astaxanthin, calculated on the basis of compound III used = finished product mass of astaxanthin x content of all-trans astaxanthin/596.86 x 164/5.65
Comparative example 1
Preparing strong alkali liquor: 5.2g of sodium hydroxide was placed in a single-neck flask, 70g of ethanol (water content 10 wt%) was added, stirred and dissolved until the solution was clear and no significant sodium hydroxide remained, and transferred to a constant-pressure dropping funnel.
At the start of the reaction, a 500ml four-necked flask was flushed with nitrogen for at least 10 min. Then, 40g of the compound II, 5.65g of the compound III, 100g of dichloromethane and 40g of ethanol (with the water content of 10 wt%) are placed in a flask, sodium hydroxide is dripped when the temperature of the mixed solution in the flask is reduced to-20 ℃, the dripping speed is controlled, the sodium hydroxide is dripped for 4 hours, after the dripping is finished, the mixture is stirred at-15 ℃ and is kept for reaction for 3 hours, and the reaction process is monitored. After the reaction was completed, neutralization was carried out with 7.8g of glacial acetic acid at a constant temperature.
Then, the neutralized reaction mixture was washed with 200ml of water 4 times, and extracted with 50ml of dichloromethane each time during the water washing, and the oil phase was separated and collected. The oil phase was concentrated by vacuum distillation to recover 200-230ml dichloromethane, and the concentration was stopped.
300ml of ethanol was added to the concentrated material, and the mixture was heated in a heating apparatus at 100 ℃. Then 100ml of solvent is extracted under the condition that the internal temperature is about 78 ℃ and the heat source is 100 ℃, then 100ml of ethanol is added, and then total reflux is carried out for 3 hours under the boiling point condition.
After the total reflux is finished, cooling the materials to 20-30 ℃, carrying out suction filtration, washing a filter cake for 2 times by using 50ml of ethanol, and then placing the filter cake in a vacuum drying oven for drying for 6 hours to obtain a finished product of 18.43g of astaxanthin;
yield: according to the detection of high performance liquid chromatography, the product contains: the content of all-trans astaxanthin is 96.35 percent, the content of semiastacin is 1.21 percent, the content of astacin is 0.45 percent, and the content of cis-astaxanthin is 0.45 percent; the molar yield of all-trans astaxanthin calculated on the basis of the compound III is 86.36 percent
Comparative example 2A 500ml four-necked flask was flushed with nitrogen for at least 10 min. Then, 40g of the compound II, 5.65g of the compound III, 100g of dichloromethane, 40g of ethanol and 5.66g of sodium acetate were placed in a flask, and when the temperature of the mixed solution in the flask was lowered to-20 ℃, the reaction was maintained and monitored. Substantially no reaction and no post-treatment.
Example 1
Batch reaction material table
Preparing strong alkali liquor: 4.48g of sodium hydroxide is placed in a single-neck flask, 70g of ethanol (water content 10%) is added, the mixture is stirred and dissolved until the solution is transparent and no obvious sodium hydroxide residue is left, and the solution is transferred to a constant-pressure dropping funnel.
At the start of the reaction, a 500ml four-necked flask was flushed with nitrogen for at least 10 min. Then, 40g of the compound II, 5.65g of the compound III, 100g of dichloromethane, 40g of ethanol (with 10wt% of water content) and 5.74g of sodium acetate are placed in a flask, strong alkali liquor is dropwise added when the temperature of the mixed solution in the flask is reduced to-20 ℃, the dropwise adding speed is controlled, 4h is dropwise added, after the dropwise adding is finished, the stirring and heat preservation reaction are continuously carried out at the temperature of less than-15 ℃ for 3h, and after the reaction is finished, 6.73g of glacial acetic acid is used for neutralization at constant temperature.
Then, the neutralized reaction mixture was washed with 200ml of water 4 times, and extracted with 50ml of dichloromethane each time during the water washing, and the oil phase was separated and collected. The oil phase was concentrated by vacuum distillation to recover 200-230ml dichloromethane, and the concentration was stopped.
300ml of ethanol was added to the concentrated material, and the mixture was heated in a heating apparatus at 100 ℃. Then 100ml of solvent is extracted under the condition that the internal temperature is about 78 ℃ and the heat source is 100 ℃, then 100ml of ethanol is added, and then total reflux is carried out for 3 hours under the boiling point condition.
After the total reflux is finished, cooling the materials to 20-30 ℃, carrying out suction filtration, washing a filter cake for 2 times by using 50ml of ethanol, and then placing the filter cake in a vacuum drying oven for drying for 6 hours; 20.07g of astaxanthin product was obtained
Yield: according to high performance liquid chromatography detection, the content of all-trans astaxanthin in the product is 98.07%, the content of semiastacin is 0.79%, the content of astacin is 0.23%, and the content of cis-astaxanthin is 0.23%; the molar yield of all-trans astaxanthin, calculated on the basis of the compound III used, was 95.72%.
Monitoring the reaction processes of comparative examples 1 and 2 and example 1, and comparing the influence of weak base on the reaction at-20 ℃ by using sodium hydroxide as the base, finding that the addition of the weak base into the mixed reaction solution has relatively high reaction rate and high trans-astaxanthin content; when only sodium hydroxide is contained in the reaction liquid, the reaction rate is slow, and the trans-content of the astaxanthin is low; when only a weak base was added, C15 reacted little with C10.
Example 2
Batch reaction material table
Preparing strong alkali liquor: 5.04g of sodium hydroxide is put into a single-neck bottle, 80g of ethanol (water content is 8wt%) is added, the mixture is stirred and dissolved until the solution is transparent and no obvious sodium hydroxide residue is left, and the solution is transferred into a constant-pressure dropping funnel.
At the start of the reaction, a 500ml four-necked flask was flushed with nitrogen for at least 10 min. Then, 40g of the compound II, 5.65g of the compound III, 100g of dichloromethane, 40g of ethanol (with 8wt% of water content) and 3.81g of sodium oxalate are placed in a flask, when the temperature of the mixed solution in the flask is reduced to-25 ℃, sodium hydroxide is added dropwise, the dropwise adding speed is controlled, 4h is added dropwise, after the dropwise adding is finished, the stirring and heat preservation reaction is continued at the temperature of less than-20 ℃ for 3h, and after the reaction is finished, 7.57g of glacial acetic acid is used for neutralization at constant temperature.
Then, the neutralized reaction mixture was washed with 200ml of water 4 times, and extracted with 50ml of dichloromethane each time during the water washing, and the oil phase was separated and collected. Concentrating the oil phase by vacuum distillation, recovering 200-230ml dichloromethane, and stopping concentration
300ml of ethanol was added to the concentrated material, and the mixture was heated in a heating apparatus at 100 ℃. Then 100ml of solvent is extracted under the condition that the internal temperature is about 78 ℃ and the heat source is 100 ℃, then 100ml of ethanol is added, and then total reflux is carried out for 3 hours under the boiling point condition.
After the total reflux is finished, cooling the materials to 20-30 ℃, carrying out suction filtration, washing a filter cake for 2 times by using 50ml of ethanol, and then placing the filter cake in a vacuum drying oven for drying for 6 hours to obtain 19.97g of astaxanthin finished products;
yield: according to the detection of high performance liquid chromatography, the content of all-trans astaxanthin in the product is 97.85 percent, the content of semiastaxanthin is 0.83 percent, the content of astaxanthin is 0.21 percent, and the content of cis-astaxanthin is 0.36 percent; the molar yield of all-trans astaxanthin, calculated on the basis of compound III used, was 95.03%
Example 3
Batch reaction material table
Preparing strong alkali liquor: 3.92g of sodium hydroxide was placed in a single-neck flask, 70g of ethanol (water content 10 wt%) was added, stirred and dissolved until the solution was clear and no significant potassium hydroxide remained, and transferred to a constant pressure dropping funnel.
At the start of the reaction, a 500ml four-necked flask was flushed with nitrogen for at least 10 min. Then, 40g of the compound II, 5.65g of the compound III, 100g of dichloromethane, 30g of ethanol (with 10wt% of water content) and 7.50g of sodium oxalate are placed in a flask, when the temperature of the mixed solution in the flask is reduced to-15 ℃, potassium hydroxide is added dropwise, the dropwise adding speed is controlled, 4h is added dropwise, after the dropwise adding is finished, the stirring and heat preservation reaction is continued at the temperature of less than-10 ℃ for 3h, and after the reaction is finished, the neutralization is carried out by using 5.88g of glacial acetic acid at constant temperature.
Then, the neutralized reaction mixture was washed with 200ml of water 4 times, and extracted with 50ml of dichloromethane each time during the water washing, and the oil phase was separated and collected. Concentrating the oil phase by vacuum distillation, recovering 200-230ml dichloromethane, and stopping concentration
300ml of ethanol was added to the concentrated material, and the mixture was heated in a heating apparatus at 100 ℃. Then 100ml of solvent is extracted under the condition that the internal temperature is about 78 ℃ and the heat source is 100 ℃, then 100ml of ethanol is added, and then total reflux is carried out for 3 hours under the boiling point condition.
After the total reflux is finished, cooling the materials to 20-30 ℃, carrying out suction filtration, washing a filter cake for 2 times by using 50ml of ethanol, and then placing the filter cake in a vacuum drying oven for drying for 6 hours; 20.12g of astaxanthin was obtained as a finished product.
Yield: according to high performance liquid chromatography detection, the product contains 98.47% of all-trans astaxanthin, 0.64% of semiastaxanthin, 0.18% of astaxanthin and 0.14% of cis-astaxanthin; the molar yield of all-trans astaxanthin, calculated on the basis of the compound III used, was 96.35%.
Example 4
Batch reaction material table
Preparing strong alkali liquor: 6.28g of potassium hydroxide was placed in a single-neck flask, 80g of ethanol (water content 8wt%) was added, and the mixture was dissolved with stirring until the solution was clear and no significant potassium hydroxide remained, and transferred to a constant-pressure dropping funnel.
At the start of the reaction, a 500ml four-necked flask was flushed with nitrogen for at least 10 min. Then, 40g of the compound II, 5.65g of the compound III, 100g of dichloromethane, 40g of ethanol (with 8wt% of water content) and 8.24g of potassium acetate are placed in a flask, when the temperature of the mixed solution in the flask is reduced to-20 ℃, potassium hydroxide is added dropwise, the dropwise adding speed is controlled, 4h is added dropwise, after the dropwise adding is finished, the stirring and heat preservation reaction is continued at the temperature of less than-15 ℃ for 3h, and after the reaction is finished, 6.73g of glacial acetic acid is used for neutralization at constant temperature.
Then, the neutralized reaction mixture was washed with 200ml of water 4 times, and extracted with 50ml of dichloromethane each time during the water washing, and the oil phase was separated and collected. The oil phase was concentrated by vacuum distillation to recover 200-230ml dichloromethane, and the concentration was stopped.
300ml of ethanol was added to the concentrated material, and the mixture was heated in a heating apparatus at 100 ℃. Then 100ml of solvent is extracted under the condition that the internal temperature is about 78 ℃ and the heat source is 100 ℃, then 100ml of ethanol is added, and then total reflux is carried out for 3 hours under the boiling point condition.
After the total reflux is finished, cooling the materials to 20-30 ℃, carrying out suction filtration, washing a filter cake for 2 times by using 50ml of ethanol, and then placing the filter cake in a vacuum drying oven for drying for 6 hours; 19.98g of finished astaxanthin product are obtained.
Yield: according to the detection of high performance liquid chromatography, the content of all-trans astaxanthin in the product is 98.03%, the content of semiastaxanthin is 0.76%, the content of astaxanthin is 0.20%, and the content of cis-astaxanthin is 0.28%. The molar yield of all-trans astaxanthin, calculated on the basis of the compound III used, was 95.25%.
Claims (10)
1. A method for catalytically synthesizing astaxanthin has the following reaction formula
Characterized in that the method comprises the following steps:
1) dissolving a compound II and a compound III in a solvent, adding weak base, stirring, mixing and cooling, and controlling the temperature to be minus 25 ℃ to minus 10 ℃;
2) adding strong alkali liquor into the reaction mixture in the step 1) at a temperature of between-25 ℃ and-10 ℃ for reaction;
3) after the reaction is completed, adding acid for neutralization, extracting and separating, and concentrating the organic phase to obtain the compound I.
2. A method for the catalytic synthesis of astaxanthin according to claim 1, characterized in that: in the step 1), the weak base is selected from sodium salt or potassium salt of organic weak acid.
3. A method for the catalytic synthesis of astaxanthin according to claim 1, characterized in that: in the step 2), the strong alkali liquor is selected from alkali metal alcoholate, alkali metal hydroxide and butyl lithium homogeneous solution or suspension.
4. A method for the catalytic synthesis of astaxanthin according to claim 1, characterized in that: in the step 2), the molar ratio of the alkali in the strong alkali solution to the compound II is 1.4-2.5: 1.
5. A method for the catalytic synthesis of astaxanthin according to claim 1, characterized in that: in the step 1), the molar ratio of the compound II to the compound III is 2.0-2.2: 1, and the molar ratio of the weak base to the compound II is 0.5-1.5: 1.
6. A method for the catalytic synthesis of astaxanthin according to claim 1, characterized in that: in step 1), the solvent is selected from an alcohol solvent, a mixture of different alcohol solvents or a mixed solvent consisting of an alcohol and a water-immiscible nonpolar solvent.
7. The method for the catalytic synthesis of astaxanthin according to claim 6, characterized in that: in the step 1), the solvent is ethanol and dichloromethane in a mass ratio of 0.3-0.4: 1, and the water content of the ethanol is 8-10% by weight; the mass ratio of the solvent to the compound II is 4: 13 to 14.
8. A method for the catalytic synthesis of astaxanthin according to claim 3, characterized in that: the strong alkali solution is a homogeneous solution or suspension of sodium hydroxide or potassium hydroxide in ethanol; the water content of the ethanol for preparing the strong alkali solution is 8-10% by weight, and the mass ratio of the ethanol for preparing the strong alkali solution to the dichloromethane in the solvent is 0.7-0.8: 1.
9. A method for the catalytic synthesis of astaxanthin according to claim 1, characterized in that: in the step 2), the strong alkali liquor is continuously dripped into the reaction mixture in the step 1), the reaction time of dripping the strong alkali liquor into the reaction mixture in the step 1) is 4-10h, and after dripping is finished, the reaction is carried out for 1-6h at the temperature of minus 25 to minus 10 ℃.
10. A method for the catalytic synthesis of astaxanthin according to any one of claims 1 to 9, characterized in that it further comprises a step 4): adding ethanol into the compound I obtained by concentrating the organic phase in the step 3), heating and refluxing for 3-4 h, converting astaxanthin into full- (E) -isomer through thermal isomerization, and then cooling, filtering and drying to obtain an astaxanthin finished product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111569916.5A CN114369048B (en) | 2021-12-21 | 2021-12-21 | Method for catalytic synthesis of astaxanthin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111569916.5A CN114369048B (en) | 2021-12-21 | 2021-12-21 | Method for catalytic synthesis of astaxanthin |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114369048A true CN114369048A (en) | 2022-04-19 |
CN114369048B CN114369048B (en) | 2023-12-26 |
Family
ID=81140773
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111569916.5A Active CN114369048B (en) | 2021-12-21 | 2021-12-21 | Method for catalytic synthesis of astaxanthin |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114369048B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115784957A (en) * | 2022-12-15 | 2023-03-14 | 上虞新和成生物化工有限公司 | Method for purifying astaxanthin |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0782246A (en) * | 1993-09-04 | 1995-03-28 | Basf Ag | Manufacturing of astaxanthin |
US5654488A (en) * | 1995-03-18 | 1997-08-05 | Basf Aktiengesellschaft | Preparation of astaxanthin |
US20060088904A1 (en) * | 2004-10-01 | 2006-04-27 | Lockwood Samuel F | Methods for the synthesis of astaxanthin |
CN101454280A (en) * | 2006-05-10 | 2009-06-10 | 帝斯曼知识产权资产管理有限公司 | Process for the preparation of as taxanthin |
JP2018131390A (en) * | 2017-02-13 | 2018-08-23 | アスタファーマシューティカルズ株式会社 | Method for producing optically active astaxanthin |
CN113461583A (en) * | 2021-07-06 | 2021-10-01 | 广州智特奇生物科技股份有限公司 | Synthetic method of astaxanthin |
-
2021
- 2021-12-21 CN CN202111569916.5A patent/CN114369048B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0782246A (en) * | 1993-09-04 | 1995-03-28 | Basf Ag | Manufacturing of astaxanthin |
US5654488A (en) * | 1995-03-18 | 1997-08-05 | Basf Aktiengesellschaft | Preparation of astaxanthin |
US20060088904A1 (en) * | 2004-10-01 | 2006-04-27 | Lockwood Samuel F | Methods for the synthesis of astaxanthin |
CN101454280A (en) * | 2006-05-10 | 2009-06-10 | 帝斯曼知识产权资产管理有限公司 | Process for the preparation of as taxanthin |
JP2018131390A (en) * | 2017-02-13 | 2018-08-23 | アスタファーマシューティカルズ株式会社 | Method for producing optically active astaxanthin |
CN113461583A (en) * | 2021-07-06 | 2021-10-01 | 广州智特奇生物科技股份有限公司 | Synthetic method of astaxanthin |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115784957A (en) * | 2022-12-15 | 2023-03-14 | 上虞新和成生物化工有限公司 | Method for purifying astaxanthin |
Also Published As
Publication number | Publication date |
---|---|
CN114369048B (en) | 2023-12-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105985248B (en) | A kind of method of synthesizing amino Diaromatic compound | |
CN114369048B (en) | Method for catalytic synthesis of astaxanthin | |
WO2007128574A1 (en) | Process for the preparation of astaxanthin | |
CN107827800B (en) | Method for preparing zeaxanthin crystals from wastewater-free marigold oleoresin | |
US3879424A (en) | Intermediate for the synthesis of zeaxanthins, xanthophylls, and 3-{62 -carotene | |
CN114426508B (en) | Preparation method of beta-carotene intermediate polyene thioether | |
JP2006507332A (en) | Method for producing carotenoid | |
EP1716092B1 (en) | Method for producing 2,7-dimethyl-octa-2,4,6-trienedial | |
CN103566972B (en) | A kind of Ferrocene oligomer and preparation method thereof | |
CN113698276B (en) | Synthesis method of 2, 6-dihydroxytoluene | |
CN114044735B (en) | Method for synthesizing tetra-acetal | |
CN113999196B (en) | Preparation method of 4- (2-nitrophenyl) dibenzo [ b, d ] furan | |
CN113292468B (en) | Preparation method of all-trans beta-carotene | |
Horiike et al. | Synthesis of insect sex pheromones and their homologues;(Z)-6-Alkenyl acetates from the Wittig reaction | |
US4064183A (en) | Synthesis of vitamin A, intermediates and conversion thereof to vitamin A | |
CN110128246B (en) | Preparation method of hydroxytyrosol | |
US4082791A (en) | Intermediates for vitamin a | |
US3661997A (en) | Mono-oxo carotenes | |
CN111747876A (en) | Method for preparing astaxanthin by oxidizing canthaxanthin | |
CN111072450A (en) | Synthesis method of allyl alcohol derivative | |
CN113880698B (en) | Preparation method of 9, 10-dibutoxyanthracene | |
CN111205184A (en) | Method for synthesizing (9Z,12E) -tetradeca-9, 12-diene-1-alcohol acetate | |
US4035425A (en) | Synthesis of Vitamin A, intermediates and conversion thereof to Vitamin A | |
CN115536494B (en) | Synthesis method of 1- (4-bromophenyl) -1, 4-butanediol | |
CN115385837B (en) | Method for preparing astaxanthin by oxidation of canthaxanthin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |